Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2025-02-20 00:00:00 ET · period of report 2025-02-18 · accession 0001437749-25-004598 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-20 | 2025-02-18 | LMAT | Roberts David B | Pres, Dir | A - Grant | $0.00 | +129 | 14.7K | +0.9% | $0 |
| D | 2025-02-20 | 2025-02-18 | LMAT | Roberts David B | Pres, Dir | A - Grant | $0.00 | +741 | 741 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-18 | A | A | 129 | $0.00 | 14,671 | D | — | — | (F1) Represents a restricted stock unit award that vests on a time-based schedule as follows: 25% of the award vests on December 6, 2025, 2026, 2027 and 2028. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-02-18 | A | A | 741 | $0.00 | 741 | D | $100.74 · 2025-02-18 to 2032-02-18 | 741 Common Stock | (F2) This option is exercisable and vests over a four-year period at a rate of 25% on December 6, 2025, 2026, 2027 and 2028. |